Celltrion Inc.
Adalimumab Immunology & rheumatology
Originator: Humira · AbbVie (originally developed and marketed by Abbott Laboratories; initial U.S. approval 2002)
| Brand | Strength | Form |
|---|---|---|
| Yuflyma | 40 mg/0.4 mL | — |
Bevacizumab Cancer (oncology)
Originator: Avastin · Genentech, Inc. / F. Hoffmann-La Roche Ltd
| Brand | Strength | Form |
|---|---|---|
| Vegzelma (bevacizumab-adcd) | 100 mg/4 mL and 400 mg/16 mL | — |
Infliximab Immunology & rheumatology
Originator: Remicade · Janssen Biotech / Johnson & Johnson (originally Centocor); initial U.S. approval 1998
| Brand | Strength | Form |
|---|---|---|
| Remsima (CT-P13) | 100 mg/20 mL vial (also subcutaneous Remsima SC in some markets) | — |
Rituximab Cancer (oncology)
Originator: Rituxan · Genentech, Inc. (a member of the Roche Group), with Biogen; Rituxan is jointly marketed by Biogen and Genentech USA in the US; MabThera is marketed by Roche
| Brand | Strength | Form |
|---|---|---|
| Truxima (rituximab-abbs) | 100 mg/10 mL and 500 mg/50 mL vials | — |
Trastuzumab Cancer (oncology)
Originator: Herceptin · Genentech, Inc. / F. Hoffmann-La Roche Ltd
| Brand | Strength | Form |
|---|---|---|
| Herzuma (trastuzumab-pkrb) | 150 mg and 440 mg vials | — |
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.
